Ferriprox FDA Approval History
FDA Approved: Yes (First approved October 14, 2011)
Brand name: Ferriprox
Generic name: deferiprone
Dosage form: Tablets and Oral Solution
Company: ApoPharma Inc.
Treatment for: Thalassemia, Iron Overload
Ferriprox (deferiprone) is an iron chelator indicated for the treatment of patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate.
Development Timeline for Ferriprox
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.